Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × fluzoparib × Clear all

NCT04102124 2025-06-24

A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC

Phase 2 Terminated

Prostatic Neoplasms

NCT06971211 2025-05-14

PARTOM

Phase 2 Recruiting

Prostatic Neoplasms

NCT05223582 2023-12-08

Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial

Phase 2 Unknown

Prostatic Neoplasms